RANDOMIZED CONTROLLED TRIAL of ADJUNCTIVE ROSUVASTATIN for TUBERCULOSIS TREATMENT

Category Primary study
JournalTopics in Antiviral Medicine
Year 2022
This article has no abstract
Epistemonikos ID: 4db98b3922b50bc5ee3f4e17a155f837afdb9d6c
First added on: Feb 14, 2025